(Q43698637)

26 November 2017

VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery (English)

1 reference

26 November 2017

1 reference

Dagar S

1

1 reference

26 November 2017

Sekosan M

2

1 reference

26 November 2017

Lee BS

3

1 reference

26 November 2017

Rubinstein I

4

1 reference

26 November 2017

Onyüksel H

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Journal of Controlled Release

26 November 2017

1 reference

26 November 2017

74

1 reference

26 November 2017

1-3

1 reference

26 November 2017

129-134

1 reference

National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900326-1

7 January 2021

Ten-year risk of false positive screening mammograms and clinical breast examinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900326-1

7 January 2021

Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900326-1

7 January 2021

Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900326-1

7 January 2021

Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900326-1

7 January 2021

10.1016/S0168-3659(01)00326-1

Identifiers

DOI

1 reference

26 November 2017

1 reference